Literature DB >> 17878469

Exacerbations of chronic obstructive pulmonary disease.

Antonio Anzueto1, Sanjay Sethi, Fernando J Martinez.   

Abstract

The diagnosis and treatment of acute exacerbations (AEs) of chronic obstructive pulmonary disease (COPD) is controversial. In this section, we review (1) the epidemiology of this condition; (2) the etiology--many patients with AECOPD are thought to have a combination of viral and bacterial infections, which contribute to their exacerbation. Bacterial organisms are isolated more commonly after viral infections in patients with COPD. The role that bacterial infections play in AECOPD remains a very controversial topic; (3) the use of diagnostic procedures; (4) efficacy of antibiotics; (5) clinical parameters to stratify patients' severity; (6) different groups of antibiotics that can be used; and (7) other therapies, including bronchodilators. We summarize the current literature, with special emphasis on the assessment of the long-term impact of this condition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17878469     DOI: 10.1513/pats.200701-003FM

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  46 in total

Review 1.  Stress responses affecting homeostasis of the alveolar capillary unit.

Authors:  Rubin M Tuder; Toshinori Yoshida
Journal:  Proc Am Thorac Soc       Date:  2011-11

2.  Chronic obstructive pulmonary disease: a view from the NHLBI.

Authors:  Antonello Punturieri; Thomas L Croxton; Gail G Weinmann; James P Kiley
Journal:  Am J Respir Crit Care Med       Date:  2008-09-01       Impact factor: 21.405

Review 3.  The role of Toll-like receptors in age-associated lung diseases.

Authors:  Maria Volkova; Yitao Zhang; Albert C Shaw; Patty J Lee
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-05       Impact factor: 6.053

4.  A novel function of MUC18: amplification of lung inflammation during bacterial infection.

Authors:  Qun Wu; Stephanie R Case; Maisha N Minor; Di Jiang; Richard J Martin; Russell P Bowler; Jieru Wang; John Hartney; Anis Karimpour-Fard; Hong Wei Chu
Journal:  Am J Pathol       Date:  2012-12-17       Impact factor: 4.307

Review 5.  Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations.

Authors:  Thomas Glaab; Claus Vogelmeier; Roland Buhl
Journal:  Respir Res       Date:  2010-06-17

6.  Validity of PROMIS physical function measured in diverse clinical samples.

Authors:  Benjamin D Schalet; Ron D Hays; Sally E Jensen; Jennifer L Beaumont; James F Fries; David Cella
Journal:  J Clin Epidemiol       Date:  2016-03-09       Impact factor: 6.437

Review 7.  Chronic obstructive pulmonary disease: an update on diagnosis and management issues in older adults.

Authors:  Shoab A Nazir; Marcia L Erbland
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

8.  Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia.

Authors:  Oriol Sibila; Eric M Mortensen; Antonio Anzueto; Elena Laserna; Marcos I Restrepo
Journal:  Eur Respir J       Date:  2013-04-18       Impact factor: 16.671

Review 9.  Chronic obstructive pulmonary disease exacerbations: latest evidence and clinical implications.

Authors:  Hammad Qureshi; Amir Sharafkhaneh; Nicola A Hanania
Journal:  Ther Adv Chronic Dis       Date:  2014-09       Impact factor: 5.091

10.  Reactive oxygen species in peripheral blood and sputum neutrophils during bacterial and nonbacterial acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Mindaugas Vaitkus; Simona Lavinskiene; Diana Barkauskiene; Kristina Bieksiene; Jolanta Jeroch; Raimundas Sakalauskas
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.